The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2 adrenoceptors.
Rohrer
D K
DK
Department of Pediatrics, Stanford University, California 94305, USA.
Bernstein
D
D
Chruscinski
A
A
Desai
K H
KH
Schauble
E
E
Kobilka
B K
BK
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D003433:Crosses, Genetic; D006720:Homozygote; D007093:Imidazoles / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D018345:Mice, Knockout; D010869:Pindolol / Q000031:analogs & derivatives / Q000378:metabolism; D018342:Receptors, Adrenergic, beta-1 / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D018343:Receptors, Adrenergic, beta-2 / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D013234:Stem Cells
D000319:Adrenergic beta-Antagonists; D007093:Imidazoles; D018342:Receptors, Adrenergic, beta-1; D018343:Receptors, Adrenergic, beta-2; C047975:cyanopindolol; D010869:Pindolol; C049763:CGP 20712A